The use of CTPs is about to get more complicated, based on the Hospital Based Outpatient Payment System proposed rule.
On second thought, maybe it’s the dog that needs to worry.
I call this the “positive Reese’s sign.”
The Medicare Advantage plans in my area have been following the “Nancy Reagan” approach to any cellular and/or tissue based product (CTP) that was cleared through the 510k pathway – which is, “Just say no.”
Lymphedema may be the most common chronic problem linked to non-healing wounds and in many cases, we don’t actually know why patients have it.
I have the most amazing wound clinic staff EVER.
Every single day – a wound center is better than any episode of “House.”